Vaccine makers preparing in case tweaks needed due to omicron variant

Concern over the omicron variant have led Pfizer and Moderna to prepare to tweak their COVID-19 vaccines if a variant that evades the current vaccines emerges.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting